Publication | Closed Access

Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors

Th2 CellsSignal TransductionChemokine BiologyChemokine Receptor ExpressionMedicineImmunologyCellular PharmacologyTh2 Chemokine ProductionAnti-cancer AgentMetronomic ChemotherapyImmunotherapyPharmacologyCell BiologyCell SignalingDrug Discovery